MPLX Stock Analysis: MPLX | NYSE
Oil & Gas Midstream | NYSE, USA | Market Cap: 57.353m USD | 12M Return: 21.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 78.7M
EPS Trend: 95.7%
Qual. Beats: -1
Rev. Trend: 95.5%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
MPLX LP is a U.S.-based midstream energy infrastructure and logistics company headquartered in Findlay, Ohio, and operates as a subsidiary of Marathon Petroleum Corporation. The company is organized into two reporting segments: Crude Oil and Products Logistics, and Natural Gas and NGL Services, covering the gathering, processing, transportation, fractionation, storage, and marketing of crude oil, natural gas, natural gas liquids, refined products, and other hydrocarbon-based and renewable products.
Beyond its pipeline and processing operations, MPLX runs an inland marine business using boats and barges to move light products, heavy oils, crude oil, renewable fuels, chemicals, and feedstocks across the Mid-Continent and Gulf Coast regions, and operates a marine repair facility on the Ohio River. It also manages terminal, rail, and storage cavern assets that support the receipt, storage, blending, additization, handling, and redelivery of refined petroleum products via pipeline, rail, marine, and truck transport. MPLX GP LLC serves as the companys general partner, and MPLX has been publicly traded on the NYSE since its 2012 IPO.
As a master limited partnership (MLP) in the GICS Oil & Gas Storage & Transportation sub-industry, MPLX generates the majority of its revenue from fee-based, volume-driven services rather than commodity price exposure, a structure typical of midstream operators that helps insulate cash flows from direct oil and gas price volatility.
- Permian natural gas processing volumes expand segment revenue
- NGL fractionation capacity supports fee-based growth
- Distribution increases and buybacks boost shareholder returns
| Net Income: 4.70b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -0.78 > 1.0 |
| NWC/Revenue: 2.67% < 20% (prev 3.15%; Δ -0.48% < -1%) |
| CFO/TA 0.14 > 3% & CFO 6.01b > Net Income 4.70b |
| Net Debt (25.1b) to EBITDA (7.21b): 3.48 < 3 |
| Current Ratio: 1.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.02b) vs 12m ago -0.29% < -2% |
| Gross Margin: 48.98% > 18% (prev 44.15%; Δ 4.83% > 0.5%) |
| Asset Turnover: 30.20% > 50% (prev 28.71%; Δ 1.49% > 0%) |
| Interest Coverage Ratio: 5.32 > 6 (EBIT TTM 5.83b / Interest Expense TTM 1.10b) |
| DSRI: 0.92 (Receivables 1.77b/1.75b, Revenue 12.4b/11.2b) |
| GMI: 0.90 (GM 44.15% / 48.98%) |
| AQI: 1.04 (AQ_t 0.39 / AQ_t-1 0.38) |
| SGI: 1.11 (Revenue 12.4b / 11.2b) |
| TATA: -0.03 (NI 4.70b - CFO 6.01b) / TA 42.9b) |
| Beneish M = -3.09 (Cap -4..+1) = AA |
As of July 05, 2026, the stock is trading at USD 57.16 with a total of 1,022,300 shares traded. Over the past week, the price has changed by +1.94%, over one month by +3.44%, over three months by +4.70% and over the past year by +21.15%.
Current recommended Stop Loss: 55.70 (which is 2.6% or 1.4 ATR below the current price).
MPLX has received a consensus analysts rating of 3.80. Therefore, it is recommended to hold MPLX.
- StrongBuy: 4
- Buy: 5
- Hold: 5
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 60.7 | 6.2% |
P/E Trailing = 12.2338
P/E Forward = 12.3916
P/S = 4.8873
P/B = 4.076
P/EG = 3.3773
Revenue TTM = 12.4b USD
EBIT TTM = 5.83b USD
EBITDA TTM = 7.21b USD
Long Term Debt = 24.4b USD (from longTermDebt, last quarter)
Short Term Debt = 1.31b USD (from shortTermDebt, last quarter)
Debt = 26.6b USD (from shortLongTermDebtTotal, last quarter) + Leases 500.0m
Net Debt = 25.1b USD (calculated: Debt 26.6b - CCE 1.51b)
Enterprise Value = 82.5b USD (57.4b + Debt 26.6b - CCE 1.51b)
Interest Coverage Ratio = 5.32 (Ebit TTM 5.83b / Interest Expense TTM 1.10b)
EV/FCF = 16.54x (Enterprise Value 82.5b / FCF TTM 4.99b)
FCF Yield = 6.05% (FCF TTM 4.99b / Enterprise Value 82.5b)
FCF Margin = 40.33% (FCF TTM 4.99b / Revenue TTM 12.4b)
Net Margin = 37.99% (Net Income TTM 4.70b / Revenue TTM 12.4b)
Gross Margin = 48.98% ((Revenue TTM 12.4b - Cost of Revenue TTM 6.31b) / Revenue TTM)
Gross Margin QoQ = 41.01% (prev 47.30%)
Tobins Q-Ratio = 1.92 (Enterprise Value 82.5b / Total Assets 42.9b)
Interest Expense / Debt = 4.12% (Interest Expense 1.10b / Debt 26.6b)
Taxrate = 0.17% (8.00m / 4.75b)
NOPAT = 5.82b (EBIT 5.83b * (1 - 0.17%))
Current Ratio = 1.10 (Total Current Assets 3.52b / Total Current Liabilities 3.19b)
Debt / Equity = 1.89 (Debt 26.6b / totalStockholderEquity, last quarter 14.1b)
Debt / EBITDA = 3.48 (Net Debt 25.1b / EBITDA 7.21b)
Debt / FCF = 5.04 (Net Debt 25.1b / FCF TTM 4.99b)
Total Stockholder Equity = 14.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.47% (Net Income 4.70b / Total Assets 42.9b)
RoE = 33.27% (Net Income TTM 4.70b / Total Stockholder Equity 14.1b)
RoCE = 15.14% (EBIT 5.83b / Capital Employed (Equity 14.1b + L.T.Debt 24.4b))
RoIC = 14.40% (NOPAT 5.82b / Invested Capital 40.4b)
WACC = 6.05% (E(57.4b)/V(84.0b) * Re(6.95%) + D(26.6b)/V(84.0b) * Rd(4.12%) * (1-Tc(0.00)))
Discount Rate = 6.95% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 2.45 | Cagr: 0.62%
[DCF] Terminal Value 75.86% ; FCFF base≈4.93b ; Y1≈5.08b ; Y5≈5.67b
[DCF] Fair Price = 61.67 (EV 87.7b - Net Debt 25.1b = Equity 62.6b / Shares 1.01b; r=8.35% [WACC [floored]]; 5y FCF grow 3.21% → 2.50% )
EPS Correlation: 95.72 | EPS CAGR: 11.28% | SUE: -1.11 | # QB: -1
Revenue Correlation: 95.49 | Revenue CAGR: 7.70% | SUE: -0.48 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.17 | Chg30d=+5.72% | Revisions=+40% | Analysts=3
EPS next Quarter (2026-09-30): EPS=1.23 | Chg30d=+8.54% | Revisions=+40% | Analysts=3
EPS current Year (2026-12-31): EPS=4.58 | Chg30d=+0.54% | Revisions=-17% | GrowthEPS=+5.6% | GrowthRev=-0.1%
EPS next Year (2027-12-31): EPS=4.94 | Chg30d=+0.17% | Revisions=+17% | GrowthEPS=+7.9% | GrowthRev=+6.4%
[Analyst] Revisions Ratio: +31% (up=7, down=3)